|
HPS5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.53582999999902E-05 |
| Normal-vs-Stage3 |
9.8714003637923E-10 |
| Normal-vs-Stage4 |
1.827260E-04 |
| Stage1-vs-Stage2 |
4.716400E-01 |
| Stage1-vs-Stage3 |
7.334400E-01 |
| Stage1-vs-Stage4 |
1.319620E-01 |
| Stage2-vs-Stage3 |
7.079200E-01 |
| Stage2-vs-Stage4 |
5.592400E-01 |
| Stage3-vs-Stage4 |
2.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62891922173003E-12 |
| Normal-vs-AfricanAmerican |
3.35209637825074E-11 |
| Normal-vs-Asian |
7.004400E-01 |
| Caucasian-vs-AfricanAmerican |
4.042100E-02 |
| Caucasian-vs-Asian |
1.365990E-01 |
| AfricanAmerican-vs-Asian |
1.645580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63122856836162E-14 |
| Normal-vs-Female |
2.29816166097407E-14 |
| Male-vs-Female |
5.577200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.572000E-04 |
| Normal-vs-Age(41-60Yrs) |
2.14606110660043E-12 |
| Normal-vs-Age(61-80Yrs) |
7.03881397612349E-14 |
| Normal-vs-Age(81-100Yrs) |
1.011190E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.790600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.130800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.454400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.971000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.614400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.643200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.42999999996896E-06 |
| Normal-vs-Grade 2 |
1.77635683940025E-15 |
| Normal-vs-Grade 3 |
1.63746793901964E-12 |
| Normal-vs-Grade 4 |
3.158700E-03 |
| Grade 1-vs-Grade 2 |
7.682600E-01 |
| Grade 1-vs-Grade 3 |
6.669000E-01 |
| Grade 1-vs-Grade 4 |
1.240180E-01 |
| Grade 2-vs-Grade 3 |
7.403800E-01 |
| Grade 2-vs-Grade 4 |
1.012560E-01 |
| Grade 3-vs-Grade 4 |
1.407430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62581059726108E-12 |
| Normal-vs-ccB subtype |
8.51829995429654E-09 |
| ccA subtype-vs-ccB subtype |
8.256500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.05542266435077E-12 |
| Normal-vs-N1 |
9.336800E-01 |
| N0-vs-N1 |
1.762960E-01 |
|
|
